Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a rare cancer with an aggressive disease course. For patients who are medically inoperable or surgically unresectable, multi-agent systemic therapy remains an accepted standard-of-care around the world. Given the rare incidence of MPM and the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotecha, Rupesh, Tonse, Raees, Rubens, Muni, Appel, Haley, Albrecht, Federico, Kaywin, Paul, Alley, Evan W., Tom, Martin C., Mehta, Minesh P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124134/
https://www.ncbi.nlm.nih.gov/pubmed/34063225
http://dx.doi.org/10.3390/cancers13092186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124134/
https://www.ncbi.nlm.nih.gov/pubmed/34063225
http://dx.doi.org/10.3390/cancers13092186

Ejemplares similares